Fortis Healthcare has officially launched the Fortis Institute of Genomic Medicine, a groundbreaking center, which is dedicated to taking advantage of the power of genomic science to bring revolution in patient care across India.
Supported by the strong clinical ecosystem of Fortis and the broad national network of Agilus Diagnostics, institute brings together a multi -kattle team of experts – including molecular hematology, oncology, neurology, pediatrics, pathology, pathology, genomics, biographical information and artificial intelligence.
Genomics is rapidly shaping the scenario of modern medicine, offering new possibilities in personal care, especially in specialties such as oncology, cardiology and neurology. Group of Fortis Healthcare, Chief Operating Officer Anil Vinayak emphasized the importance of this initiative:
“The launch of Fortis Institute of Genomic Medicine is a strategic step towards our vision to be at the forefront of transformative healthcare. By embedding genomics in our main offerings, we are capable of personal, data-making care that enhances the patient results and strengthens our leadership in clinical innovation.”
Chief Innovation and Development Officer at Fortis Dr. Ritu Garg said, “We believe that the future of therapy lies in accurate and privatization. This institute reflects our commitment to integrate state -of -the -art science with clinical excellence to give an average impact in the care of the patient. We aim to promote innovation that is scalable, sustainable and actually transformative.”
Fortis Memorial Research Institute, Yash Rawat, at Gurugram, underlines the role of genomic testing in the management of VP and Facility Director, Chronic and non-communicable diseases, “Genomics revolutionize our perspective to detect initial disease, assess the treatment accuracy and risk. Emperor.”
Looking further, Fortis planned to launch a genomics-informed health registry, establishing new standards in accurate medicine. In addition, the institute will introduce India’s first AI-managed genomic reporting platform-the title for Indian physicians and will be aligned with international best practices with ACMG, AMP and ASCO. This platform will be obedient, clinically relevant and originally integrated into everyday medical workflow.
Disclaimer:
(The views expressed are solely on the basis of research. Indiagnostic shall not be responsible for any damage caused to any person/organization directly or indirectly).
Related posts:
Fortis Launches Institute to Revolutionize Gene-Based Disease Treatment
RML Hospital Launches Heatstroke Helpline Amid Soaring Summer Temperatures
Apollo Hospitals Plans Strategic Exit from Maternity Care Segment
Government Revokes Transplant Licenses of Two Hospitals Over Illegal Organ Trade
Kokilaben Hospital Introduces India’s First Toumai Robotic Surgery System
